Hesperidin Protects against Acute Alcoholic Injury through Improving Lipid Metabolism and Cell Damage in Zebrafish Larvae.
Zhenting ZhouWeichao ZhongHaiyan LinPeng HuangNing MaYuqing ZhangChuying ZhouYuling LaiShaohui HuangShiying HuangLei GaoZhi-Ping LvPublished in: Evidence-based complementary and alternative medicine : eCAM (2017)
Alcoholic liver disease (ALD) is a series of abnormalities of liver function, including alcoholic steatosis, steatohepatitis, and cirrhosis. Hesperidin, the major constituent of flavanone in grapefruit, is proved to play a role in antioxidation, anti-inflammation, and reducing multiple organs damage in various animal experiments. However, the underlying mechanism of resistance to alcoholic liver injury is still unclear. Thus, we aimed to investigate the protective effects of hesperidin against ALD and its molecular mechanism in this study. We established an ALD zebrafish larvae model induced by 350 mM ethanol for 32 hours, using wild-type and transgenic line with liver-specific eGFP expression Tg (lfabp10α:eGFP) zebrafish larvae (4 dpf). The results revealed that hesperidin dramatically reduced the hepatic morphological damage and the expressions of alcohol and lipid metabolism related genes, including cyp2y3, cyp3a65, hmgcra, hmgcrb, fasn, and fads2 compared with ALD model. Moreover, the findings demonstrated that hesperidin alleviated hepatic damage as well, which is reflected by the expressions of endoplasmic reticulum stress and DNA damage related genes (chop, gadd45αa, and edem1). In conclusion, this study revealed that hesperidin can inhibit alcoholic damage to liver of zebrafish larvae by reducing endoplasmic reticulum stress and DNA damage, regulating alcohol and lipid metabolism.
Keyphrases
- liver injury
- drug induced
- endoplasmic reticulum stress
- oxidative stress
- dna damage
- induced apoptosis
- single cell
- aedes aegypti
- fatty acid
- drosophila melanogaster
- cell therapy
- stem cells
- type diabetes
- high fat diet
- insulin resistance
- adipose tissue
- mesenchymal stem cells
- metabolic syndrome
- diffuse large b cell lymphoma
- mechanical ventilation